A carregar...
Safety Strategies of Genetically Engineered T Cells in Cancer Immunotherapy
T-cell therapy using genetically engineered T cells modified with either T cell receptor or chi-meric antigen receptor holds great promise for cancer immunotherapy. The concerns about its toxicities still remain despite recent successes in clinical trials. Temporal and spatial control of the enginee...
Na minha lista:
| Publicado no: | Curr Pharm Des |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bentham Science Publishers
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5876919/ https://ncbi.nlm.nih.gov/pubmed/29283058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1381612824666171227222624 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|